The implantable pulse generator market size has grown rapidly in recent years. It will grow from $147.01 billion in 2025 to $162.9 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to rising prevalence of chronic pain conditions, increasing incidence of cardiovascular diseases, growing adoption of implantable medical devices, expansion of hospital-based surgical procedures, rising awareness of neuromodulation therapies.
The implantable pulse generator market size is expected to see rapid growth in the next few years. It will grow to $245.56 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive treatments, growing aging population, rising burden of neurological disorders, expanding access to advanced implantable therapies, increasing focus on long-term disease management. Major trends in the forecast period include growing adoption of neuromodulation therapies, rising use of implantable pulse generators for chronic pain management, increasing preference for rechargeable implantable pulse generators, expansion of implantable pulse generator applications in movement disorders, growing demand for long-term implantable stimulation devices.
The increasing prevalence of neurological disorders is expected to drive the growth of the implantable pulse generator market. Neurological disorders affect the brain, spinal cord, and nervous system, impacting movement, sensation, and cognition. The rise in these disorders is linked to factors such as an aging population, lifestyle changes, environmental influences, and advancements in diagnostic techniques. Implantable pulse generators assist in managing neurological disorders by delivering targeted electrical impulses to modulate abnormal neural activity and alleviate symptoms. For example, in October 2023, the World Federation of Neurology, a UK-based non-profit organization, reported that over 40% of the global population currently experiences a neurological condition, and this burden is projected to nearly double in the coming years. Thus, the growing incidence of neurological disorders is fueling the expansion of the implantable pulse generator market.
Major companies in the implantable pulse generator (IPG) market are focusing on MRI-conditional neurostimulators, including sensing-enabled rechargeable IPGs, to strengthen their competitive position. For example, in April 2024, Medtronic, a US-based healthcare company, received FDA approval for its Inceptiv closed-loop spinal cord stimulator, which monitors evoked compound action potentials (ECAPs) 50 times per second to adjust stimulation in real time while permitting full-body 1.5 T and 3 T MRI scans. Similarly, in January 2024, Medtronic launched the Percept RC rechargeable deep brain stimulation neurostimulator, equipped with BrainSense sensing technology, a 15-year battery life, and full-body MRI compatibility at 1.5 T and 3 T with therapy active. These innovations improve therapy personalization and patient safety, although they may involve higher development and device costs.
In October 2025, Boston Scientific Corporation, a US-based health technology company, acquired Nalu Medical, Inc. for an undisclosed amount. Through this acquisition, Boston Scientific aims to expand and strengthen its neuromodulation portfolio for chronic pain management. Nalu Medical, Inc. is a US-based medical equipment manufacturer specializing in implantable pulse generators.
Major companies operating in the implantable pulse generator market are Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Nevro Corp, LivaNova PLC, NeuroPace Inc, NeuroSigma Inc, Saluda Medical Pty Ltd, Synapse Biomedical Inc, Nuvectra Medical Inc, MainStay Medical International PLC, Aleva Neurotherapeutics SA, Bioness Inc, EnteroMedics Inc, Neuronetics Inc, Axonics Inc, Sceneray Co Ltd, Cirtec Medical, BlueWind Medical, Syntach AB, Osaka Medical Devices, Gimer Medical, Saluda Medical.
North America was the largest region in the implantable pulse generator market in 2025. The regions covered in the implantable pulse generator market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the implantable pulse generator market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have introduced supply chain disruptions and cost pressures in the implantable pulse generator market by increasing import duties on electronic components, batteries, and precision medical-grade materials. These impacts have raised manufacturing costs and affected pricing across rechargeable and non rechargeable devices, with north america and asia-pacific regions being most impacted due to globalized sourcing dependencies. Hospitals and ambulatory surgical centers have faced higher procurement costs, influencing purchasing decisions and reimbursement dynamics. On the positive side, tariffs have encouraged domestic manufacturing investments, supplier diversification, and localized production strategies, improving long-term supply chain resilience.
The implantable pulse generator market research report is one of a series of new reports that provides implantable pulse generator market statistics, including implantable pulse generator industry global market size, regional shares, competitors with a implantable pulse generator market share, detailed implantable pulse generator market segments, market trends and opportunities, and any further data you may need to thrive in the implantable pulse generator industry. This implantable pulse generator market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An implantable pulse generator (IPG) is a medical device used to deliver electrical impulses to specific nerves or muscles within the body. It is commonly employed in neuromodulation therapies to manage conditions such as chronic pain or movement disorders. The IPG is surgically implanted under the skin and can be programmed to adjust stimulation levels as required.
The primary types of implantable pulse generators include implantable cardiac pacemakers, implantable defibrillators, cochlear implants, implantable nerve stimulators (functional electrical stimulation or FES), implantable infusion pumps, and implantable active monitoring devices. Implantable cardiac pacemakers, for example, are devices placed in the chest to regulate abnormal heart rhythms by delivering electrical impulses to stimulate the heart. They come in rechargeable and non-rechargeable variants and are used for cardiovascular diseases, movement disorders, orthopedic conditions, and other health issues. End users of these devices include hospitals, ambulatory surgical centers, home care settings, and clinics.
The implantable pulse generator market consists of sales of neurostimulators, sacral nerve stimulators, and deep brain stimulation (DBS) systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The implantable pulse generator market size is expected to see rapid growth in the next few years. It will grow to $245.56 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive treatments, growing aging population, rising burden of neurological disorders, expanding access to advanced implantable therapies, increasing focus on long-term disease management. Major trends in the forecast period include growing adoption of neuromodulation therapies, rising use of implantable pulse generators for chronic pain management, increasing preference for rechargeable implantable pulse generators, expansion of implantable pulse generator applications in movement disorders, growing demand for long-term implantable stimulation devices.
The increasing prevalence of neurological disorders is expected to drive the growth of the implantable pulse generator market. Neurological disorders affect the brain, spinal cord, and nervous system, impacting movement, sensation, and cognition. The rise in these disorders is linked to factors such as an aging population, lifestyle changes, environmental influences, and advancements in diagnostic techniques. Implantable pulse generators assist in managing neurological disorders by delivering targeted electrical impulses to modulate abnormal neural activity and alleviate symptoms. For example, in October 2023, the World Federation of Neurology, a UK-based non-profit organization, reported that over 40% of the global population currently experiences a neurological condition, and this burden is projected to nearly double in the coming years. Thus, the growing incidence of neurological disorders is fueling the expansion of the implantable pulse generator market.
Major companies in the implantable pulse generator (IPG) market are focusing on MRI-conditional neurostimulators, including sensing-enabled rechargeable IPGs, to strengthen their competitive position. For example, in April 2024, Medtronic, a US-based healthcare company, received FDA approval for its Inceptiv closed-loop spinal cord stimulator, which monitors evoked compound action potentials (ECAPs) 50 times per second to adjust stimulation in real time while permitting full-body 1.5 T and 3 T MRI scans. Similarly, in January 2024, Medtronic launched the Percept RC rechargeable deep brain stimulation neurostimulator, equipped with BrainSense sensing technology, a 15-year battery life, and full-body MRI compatibility at 1.5 T and 3 T with therapy active. These innovations improve therapy personalization and patient safety, although they may involve higher development and device costs.
In October 2025, Boston Scientific Corporation, a US-based health technology company, acquired Nalu Medical, Inc. for an undisclosed amount. Through this acquisition, Boston Scientific aims to expand and strengthen its neuromodulation portfolio for chronic pain management. Nalu Medical, Inc. is a US-based medical equipment manufacturer specializing in implantable pulse generators.
Major companies operating in the implantable pulse generator market are Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Nevro Corp, LivaNova PLC, NeuroPace Inc, NeuroSigma Inc, Saluda Medical Pty Ltd, Synapse Biomedical Inc, Nuvectra Medical Inc, MainStay Medical International PLC, Aleva Neurotherapeutics SA, Bioness Inc, EnteroMedics Inc, Neuronetics Inc, Axonics Inc, Sceneray Co Ltd, Cirtec Medical, BlueWind Medical, Syntach AB, Osaka Medical Devices, Gimer Medical, Saluda Medical.
North America was the largest region in the implantable pulse generator market in 2025. The regions covered in the implantable pulse generator market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the implantable pulse generator market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have introduced supply chain disruptions and cost pressures in the implantable pulse generator market by increasing import duties on electronic components, batteries, and precision medical-grade materials. These impacts have raised manufacturing costs and affected pricing across rechargeable and non rechargeable devices, with north america and asia-pacific regions being most impacted due to globalized sourcing dependencies. Hospitals and ambulatory surgical centers have faced higher procurement costs, influencing purchasing decisions and reimbursement dynamics. On the positive side, tariffs have encouraged domestic manufacturing investments, supplier diversification, and localized production strategies, improving long-term supply chain resilience.
The implantable pulse generator market research report is one of a series of new reports that provides implantable pulse generator market statistics, including implantable pulse generator industry global market size, regional shares, competitors with a implantable pulse generator market share, detailed implantable pulse generator market segments, market trends and opportunities, and any further data you may need to thrive in the implantable pulse generator industry. This implantable pulse generator market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An implantable pulse generator (IPG) is a medical device used to deliver electrical impulses to specific nerves or muscles within the body. It is commonly employed in neuromodulation therapies to manage conditions such as chronic pain or movement disorders. The IPG is surgically implanted under the skin and can be programmed to adjust stimulation levels as required.
The primary types of implantable pulse generators include implantable cardiac pacemakers, implantable defibrillators, cochlear implants, implantable nerve stimulators (functional electrical stimulation or FES), implantable infusion pumps, and implantable active monitoring devices. Implantable cardiac pacemakers, for example, are devices placed in the chest to regulate abnormal heart rhythms by delivering electrical impulses to stimulate the heart. They come in rechargeable and non-rechargeable variants and are used for cardiovascular diseases, movement disorders, orthopedic conditions, and other health issues. End users of these devices include hospitals, ambulatory surgical centers, home care settings, and clinics.
The implantable pulse generator market consists of sales of neurostimulators, sacral nerve stimulators, and deep brain stimulation (DBS) systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Implantable Pulse Generator Market Characteristics
3. Implantable Pulse Generator Market Supply Chain Analysis
4. Global Implantable Pulse Generator Market Trends and Strategies
5. Implantable Pulse Generator Market Analysis of End Use Industries
7. Global Implantable Pulse Generator Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Implantable Pulse Generator Total Addressable Market (TAM) Analysis for the Market
9. Implantable Pulse Generator Market Segmentation
10. Implantable Pulse Generator Market Regional and Country Analysis
11. Asia-Pacific Implantable Pulse Generator Market
12. China Implantable Pulse Generator Market
13. India Implantable Pulse Generator Market
14. Japan Implantable Pulse Generator Market
15. Australia Implantable Pulse Generator Market
16. Indonesia Implantable Pulse Generator Market
17. South Korea Implantable Pulse Generator Market
18. Taiwan Implantable Pulse Generator Market
19. South East Asia Implantable Pulse Generator Market
20. Western Europe Implantable Pulse Generator Market
21. UK Implantable Pulse Generator Market
22. Germany Implantable Pulse Generator Market
23. France Implantable Pulse Generator Market
24. Italy Implantable Pulse Generator Market
25. Spain Implantable Pulse Generator Market
26. Eastern Europe Implantable Pulse Generator Market
27. Russia Implantable Pulse Generator Market
28. North America Implantable Pulse Generator Market
29. USA Implantable Pulse Generator Market
30. Canada Implantable Pulse Generator Market
31. South America Implantable Pulse Generator Market
32. Brazil Implantable Pulse Generator Market
33. Middle East Implantable Pulse Generator Market
34. Africa Implantable Pulse Generator Market
36. Implantable Pulse Generator Market Competitive Landscape and Company Profiles
37. Implantable Pulse Generator Market Other Major and Innovative Companies
40. Implantable Pulse Generator Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Implantable Pulse Generator Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses implantable pulse generator market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for implantable pulse generator? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable pulse generator market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Functional Electrical Stimulation (FES) Devices for Motor Function Restoration; Spinal Cord Stimulation (SCS) Devices; Deep Brain Stimulation (DBS) Devices; Vagus Nerve Stimulation (VNS) Devices; Sacral Nerve Stimulation (SNS) Devices2) By Charging Type: Rechargeable; Non-Rechargeable
3) By Application: Movement Disorders; Chronic Pain Management; Neurological Disorders; Other Applications
4) By End User: Hospitals; Ambulatory Surgical Centers; Clinics; Home Care and Remote Monitoring Settings
Subsegments:
1) By Functional Electrical Stimulation (FES) Devices: For Motor Function Restoration; For Muscle Strengthening; For Rehabilitation Post-Stroke or Injury2) By Spinal Cord Stimulation (SCS) Devices: Conventional SCS Systems; High-Frequency SCS Systems; Burst SCS Systems
3) By Deep Brain Stimulation (DBS) Devices: Parkinson’s Disease DBS Systems; Essential Tremor DBS Systems; Dystonia DBS Systems; Other Neurological Disorder DBS Systems
4) By Vagus Nerve Stimulation (VNS) Devices: Epilepsy Treatment VNS Devices; Depression Treatment VNS Devices
5) By Sacral Nerve Stimulation (SNS) Devices: Urinary Incontinence SNS Devices; Fecal Incontinence SNS Devices; Other Pelvic Floor Disorder SNS Devices
Companies Mentioned: Abbott Laboratories; Boston Scientific Corporation; Medtronic PLC; Nevro Corp; LivaNova PLC; NeuroPace Inc; NeuroSigma Inc; Saluda Medical Pty Ltd; Synapse Biomedical Inc; Nuvectra Medical Inc; MainStay Medical International PLC; Aleva Neurotherapeutics SA; Bioness Inc; EnteroMedics Inc; Neuronetics Inc; Axonics Inc; Sceneray Co Ltd; Cirtec Medical; BlueWind Medical; Syntach AB; Osaka Medical Devices; Gimer Medical; Saluda Medical
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Implantable Pulse Generator market report include:- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic PLC
- Nevro Corp
- LivaNova PLC
- NeuroPace Inc
- NeuroSigma Inc
- Saluda Medical Pty Ltd
- Synapse Biomedical Inc
- Nuvectra Medical Inc
- MainStay Medical International PLC
- Aleva Neurotherapeutics SA
- Bioness Inc
- EnteroMedics Inc
- Neuronetics Inc
- Axonics Inc
- Sceneray Co Ltd
- Cirtec Medical
- BlueWind Medical
- Syntach AB
- Osaka Medical Devices
- Gimer Medical
- Saluda Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 162.9 Billion |
| Forecasted Market Value ( USD | $ 245.56 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
